MagVenture NEWS

Are you interested in TMS? Stay updated and subscribe to MagVenture NEWS

Read More
Depression treatment for Patients

Do you not respond to antidepressants?
TMS is an effective alternative to medication

Read More
MagVenture Depression Treatment for healthcare professionals

Do you wish to give patients an alternative to antidepressants?

Read More
MagVenture MagPro R30 Stimulator

Magnetic stimulation systems for depression treatment, clinical examination and research

Read More
MagVenture Coils

With 7 different magnetic stimulators and 31 different coils, MagVenture is the ultimate research partner

Read More
< Back
You are here » Home

MagVita TMS Therapy receives FDA clearance

MagVita TMS-Therapie erhält FDA-Freigabe MagVenture has received FDA 510(k) clearance to market the MagVita TMS Therapy® system for Major Depressive Disorder.
MagVita TMS Therapy is indicated for adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode

Read more

MagVenture and MagPro

MagVenture® is a medical device company specializing in non-invasive magnetic stimulation systems. MagVenture’s product line MagPro® is designed especially for the needs of researchers and healthcare professionals. With 7 different magnetic stimulators and 31 different coils, the MagPro line provides a solution to most stimulation needs.

Read more

Click to read MagVenture NEWS #7
and receive MagVenture NEWS directly in your mailbox.


MagVenture News

MagVenture at ECNR, 2015
MagVenture will participate in the European Congress of NeuroRehabilitation 2015.

Read more

TMS course for physicians at CAMH in Toronto, Canada
The course takes place on November 27-28, 2015.

Read more

First European meeting for noninvasive brain stimulation techniques (NIBS) for psychiatric disorders

Read more

Meet MagVenture at SfN in Chicago

Read more

Charleston VA researchers say magnetic treatment can put depression in remission (ABC News4)

Read more

RTMS in the Elderly and After ECT (Bipolar Network News)

Read more

RTMS Study Identifies Glutamate as a Biomarker for Depression Treatment (Bipolar Network News)

Read more

MagVenture at Psych Congress in San Diego

Read more

MagVenture receives FDA clearance for TMS depression treatment system

Read more

Intensive TMS Courses in 2015 at Duke University
MagVenture, Inc. provides equipment support to Duke University for  TMS Course

Read more



Healthcare Professionals

Healthcare Professional



Download Brochure